# LY6E

## Overview
LY6E, or lymphocyte antigen 6 family member E, is a gene that encodes a glycosylphosphatidylinositol (GPI)-anchored cell surface protein involved in immune regulation and viral interactions. The LY6E protein is a member of the Ly6/uPAR superfamily, characterized by a conserved LU domain that forms a three-fingered structural motif, similar to those found in snake venom neurotoxins (Loughner2016Organization). This structural motif allows LY6E to participate in diverse intermolecular interactions, contributing to its functional versatility in modulating T cell activation and proliferation, as well as influencing viral entry and immune signaling (Yu2019Emerging; Zhao2020LY6E). The gene is expressed in various tissues and can be induced by type I interferons, highlighting its role in immune responses and its potential as a therapeutic target in diseases such as cancer and viral infections (Yu2019Emerging; Zhao2020LY6E).

## Structure
The LY6E protein is a member of the Ly6/uPAR superfamily, characterized by a conserved LU domain. This domain consists of approximately 80 amino acids with ten cysteines forming disulfide bridges, creating a three-fingered structural motif similar to that found in snake venom neurotoxins (Loughner2016Organization). The protein is 133 amino acids in length and is anchored to the plasma membrane via a glycosylphosphatidylinositol (GPI) moiety, which is crucial for its function in immune signaling and viral interactions (Yu2019Emerging; Zhao2020LY6E).

The GPI anchor is encoded by the third exon of the LY6E gene, which is typical for members of this protein family (Loughner2016Organization). The protein's structure includes a highly conserved three-finger folding motif, which is essential for its role in modulating viral entry and immune responses (Zhao2020LY6E). The LU domain's three-finger structure allows for diverse intermolecular interactions, contributing to the protein's functional versatility (Loughner2016Organization). The presence of a GPI-anchoring signal peptide has been experimentally confirmed, supporting its membrane localization and function (Loughner2016Organization).

## Function
LY6E, also known as Thymic Shared Antigen-1 (TSA-1) or Stem Cell Antigen-2 (SCA-2), is a glycosylphosphatidylinositol (GPI)-anchored cell surface protein that plays a significant role in immune regulation and T cell physiology. It is involved in modulating T cell activation, proliferation, and development, which are critical functions in the immune system (Yu2019Emerging; Zhao2020LY6E). LY6E is expressed in various tissues, including the liver, spleen, uterus, ovary, lung, and brain, and its expression can be induced by type I interferons (Yu2019Emerging; Zhao2020LY6E).

In healthy human cells, LY6E is primarily active on the cell surface, where it participates in cell signaling and immune response modulation. It is known to interact with the T cell receptor (TCR/CD3) complex, leading to T cell activation through CD3ζ chain tyrosine phosphorylation (Yu2019Emerging). This protein is also involved in cytoskeleton rearrangements, potentially through associations with transmembrane adaptors like Src family kinase and integrin (Yu2019Emerging). These interactions highlight LY6E's role in immune regulation and its importance in maintaining healthy immune function.

## Clinical Significance
Alterations in the expression of the LY6E gene have been implicated in various diseases, particularly cancers and viral infections. In colorectal cancer (CRC), LY6E is highly expressed in tumor tissues compared to normal tissues, serving as an independent prognostic factor for worse overall survival. Its knockdown has been shown to inhibit CRC cell proliferation, migration, and invasion, suggesting an oncogenic role (Kim2023High). Similarly, in pancreatic cancer, LY6E overexpression is associated with poor prognosis and promotes tumor growth and migration by activating the Wnt/β-catenin signaling pathway (Cen2024Lymphocyte).

LY6E also plays a significant role in viral infections. It is involved in the immune response to coronaviruses, such as SARS-CoV-2, where its absence in mice leads to increased susceptibility to infection (Mar2023LY6E). The gene modulates immune responses, and its knockout results in impaired responses to viral infections, as seen in studies involving murine hepatitis virus (DelgadoChaves2020Computational). LY6E's expression can enhance viral entry, as observed in HIV-1 infections, where it facilitates virus-cell fusion in high CD4-expressing cells but inhibits entry in low CD4-expressing cells (Yu2019Emerging).

## Interactions
LY6E, also known as lymphocyte antigen 6 family member E, participates in various interactions with proteins and nucleic acids that influence viral entry and immune signaling. It is a glycosylphosphatidyl-inositol (GPI)-anchored cell surface protein involved in immunological regulation and T cell physiology. LY6E interacts with the T cell receptor (TCR/CD3) ζ chains, which is crucial for T cell activation and can impact viral infection outcomes (Yu2019Emerging).

In the context of viral infections, LY6E has been shown to interact with the Marek's disease virus (MDV) pathogenic US10 protein in chickens, although the exact impact of this interaction on cellular physiology and viral pathogenesis remains unclear (Yu2019Emerging). LY6E also modulates the entry of flaviviruses by facilitating their internalization, possibly through interactions with the cytoskeleton, which is crucial for virus entry (Yu2019Emerging).

LY6E's role in inhibiting coronavirus fusion is attributed to its interference with spike protein-mediated membrane fusion, although it does not affect the proteolytic activation of the spike protein, suggesting a specific action on the fusion process (Pfaender2020LY6E). These interactions highlight LY6E's complex involvement in cellular processes and its potential as a therapeutic target for viral infections.


## References


[1. (Zhao2020LY6E) Xuesen Zhao, Shuangli Zheng, Danying Chen, Mei Zheng, Xinglin Li, Guoli Li, Hanxin Lin, Jinhong Chang, Hui Zeng, and Ju-Tao Guo. Ly6e restricts entry of human coronaviruses, including currently pandemic sars-cov-2. Journal of Virology, August 2020. URL: http://dx.doi.org/10.1128/jvi.00562-20, doi:10.1128/jvi.00562-20. This article has 60 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/jvi.00562-20)

2. (Pfaender2020LY6E) LY6E impairs coronavirus fusion and confers immune control of viral disease. This article has 12 citations.

[3. (Loughner2016Organization) Chelsea L. Loughner, Elspeth A. Bruford, Monica S. McAndrews, Emili E. Delp, Sudha Swamynathan, and Shivalingappa K. Swamynathan. Organization, evolution and functions of the human and mouse ly6/upar family genes. Human Genomics, April 2016. URL: http://dx.doi.org/10.1186/s40246-016-0074-2, doi:10.1186/s40246-016-0074-2. This article has 158 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s40246-016-0074-2)

[4. (Yu2019Emerging) Jingyou Yu and Shan-Lu Liu. Emerging role of ly6e in virus–host interactions. Viruses, 11(11):1020, November 2019. URL: http://dx.doi.org/10.3390/v11111020, doi:10.3390/v11111020. This article has 40 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/v11111020)

[5. (DelgadoChaves2020Computational) Fernando M. Delgado-Chaves, Francisco Gómez-Vela, Federico Divina, Miguel García-Torres, and Domingo S. Rodriguez-Baena. Computational analysis of the global effects of ly6e in the immune response to coronavirus infection using gene networks. Genes, 11(7):831, July 2020. URL: http://dx.doi.org/10.3390/genes11070831, doi:10.3390/genes11070831. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/genes11070831)

[6. (Cen2024Lymphocyte) Kenan Cen, Jingyao Zhou, Xuejia Yang, Yangyang Guo, and Yanyi Xiao. Lymphocyte antigen 6 family member e suppresses apoptosis and promotes pancreatic cancer growth and migration via wnt/β-catenin pathway activation. Scientific Reports, August 2024. URL: http://dx.doi.org/10.1038/s41598-024-70764-1, doi:10.1038/s41598-024-70764-1. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-024-70764-1)

[7. (Kim2023High) Han Kim, Inpyo Hong, Sanghyun Roh, Sooyoun Kim, Hyeongjoo Kim, Seunghyun Oh, Tae Ahn, Dong Kang, Moo-Jun Baek, and Dongjun Jeong. High expression of ly6e is an independent prognostic factor of colorectal cancer patients. Oncology Reports, March 2023. URL: http://dx.doi.org/10.3892/or.2023.8517, doi:10.3892/or.2023.8517. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/or.2023.8517)

8. (Mar2023LY6E) LY6E protects mice from pathogenic effects of murine coronavirus and SARS-CoV-2. This article has 1 citations.